Varuma AG

Varuma AG is a Swiss venture capital firm headquartered in Basel, specializing in investments within the healthcare sector. The firm focuses on late-stage ventures, providing capital to companies in the pharmaceutical and biotechnology industries. Varuma's investment strategy emphasizes supporting businesses that are poised for significant growth and market impact.

The firm's portfolio includes notable companies such as NovImmune, Addex Therapeutics, and Santhera Pharmaceuticals. These investments reflect Varuma's commitment to advancing innovative healthcare solutions and fostering the development of cutting-edge medical technologies. By partnering with these companies, Varuma aims to contribute to the evolution of the healthcare landscape.

Varuma AG operates with a team of experienced professionals, including Management Partner Hans-Beat Gürtler, who has a background as the Global Chief Executive Officer at Novartis Animal Health. The firm's leadership brings a wealth of expertise in managing and scaling healthcare enterprises, ensuring strategic guidance and value creation for its portfolio companies.